Breaking News

Black engineers work to fix bias in pulse oximeters; FDA approves fast-acting treatment for major depression

 

Daily Recap

'A poster child' for diversity in science: Black engineers work to fix long-ignored bias in oxygen readings

By Usha Lee McFarling

Courtesy Joshua Burrow

"I said, 'Wait a minute, it's an approved device and no one looked at this?'" one engineer said when told about pulse oximeters' bias.

Read More

STAT+: FDA approves Axsome's fast-acting treatment for major depression

By Damian Garde

Adobe

Auvelity is a combination of dextromethorphan, commonly found in cough suppressants, and a generic form of Wellbutrin.

Read More

Opinion: Biden's long Covid plan is a good start. But it needs to go further

By Ryan Prior and Kimberly Knackstedt

Charlie Riedel/ AP

Biden's long Covid plan identifies key points from patients, researchers, and policymakers. But it falls short of robust, far-reaching goals.

Read More

STAT+: FDA scolds Sun Pharma for allegedly backdating documents and fudging records for collecting drug samples

By Ed Silverman

Jacquelyn Martin/AP

Sun Pharma allegedly falsified various documents that were maintained by employees at one of its plants in India, according to the FDA.

Read More

Opinion: The Inflation Reduction Act: One step closer to pharmacoequity?

By Utibe R. Essien

MANDEL NGAN/ Getty

One overlooked benefit of the Inflation Reduction Act may be the law's role in reducing health disparities.

Read More

Opinion: Investing in health workers can help close the vaccination gap — and improve global health

By Amanda McClelland

Ted S. Warren/AP

Expanding the number of frontline health workers, especially nurses and community health workers, can help close the global vaccination gap.

Read More

Friday, August 19, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments